A class action claims Teva Pharmaceuticals advertises its antidepressant Budeprion XL as equivalent to Wellbutrin XL, though it releases the drug more quickly, does not work as well or for as long a time, and increases users’ risk of harmful side effects, in Columbus, Ohio, Federal Court.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

